Positrigo's vision is to image everyone. Offering innovative solutions for providing functional brain positron emission tomography scans to the masses, our first focus is the early detection of Alzheimer's Disease. With the advent of treatments like Leqembi and Kisunla, an early and reliable diagnostic technique is of utmost importance. This is where Positrigo will provide a solution with which healthcare providers, such as imaging centers and neurologists, can make more functional brain scans on the same space for lower cost than today.

News

06.11.2024 A good start in the US for four startups (startupticker.ch)
18.07.2024 Positrigo receives FDA approval for NeuroLF (startupticker.ch)
17.10.2023 Positrigo prepares for market entry (startupticker.ch)
26.08.2022 Strong Swiss delegation at Medica (startupticker.ch)

Milestones/News

18.12.2023 All IEC60601 tests successfully passed in accredited test lab
04.03.2019 First Prototype ready
17.12.2018 Horizon 2020 SME Phase 1
05.12.2018 VentureKick Stage 3

Videos and Presentations


NeuroLF Product Presentation


Pitch Venture Leaders Kufe Science 2019


SCSN 2019

Player is loading...